Tag: MORT

Declines seen across drug classes and for most states

Risk for postoperative eKA slightly increased; lower risks seen for perioperative acute kidney injury and 30-day mortality

BSO not associated with increased risk for cardiovascular diseases, ischemic heart disease, or cerebrovascular disease

Decreases seen from 1999 to 2020 in both women and men, but mortality rates persistently higher for women

Increasing trend in metabolic dysfunction-associated steatotic liver disease-related mortality steeper than that for alcohol-related liver disease mortality

Introduction of pregnancy checkbox associated with increase in reported maternal mortality of 6.78 deaths per 100,000 livebirths

Geographic disparities seen, with greater percentage of cardiovascular deaths attributable to di-2-ethylhexylphthalate exposure for South Asia, Middle East

Overall, 79 percent of Americans would want to know if they had Alzheimer disease before experiencing symptoms or before symptoms interfere

Highest incidence-based mortality seen in non-Hispanic Black women, with declines pronounced from 2016, narrowing gap with other racial groups

In a recent study, one-year MACE incidences were 1.79, 2.58, and 4.03 per 100 patient-years for early, late, and no ezetimibe added to statins